289 related articles for article (PubMed ID: 12505350)
1. Polymorphism of cytochrome P450 and xenobiotic toxicity.
Ingelman-Sundberg M
Toxicology; 2002 Dec; 181-182():447-52. PubMed ID: 12505350
[TBL] [Abstract][Full Text] [Related]
2. Genetic susceptibility to adverse effects of drugs and environmental toxicants. The role of the CYP family of enzymes.
Ingelman-Sundberg M
Mutat Res; 2001 Oct; 482(1-2):11-9. PubMed ID: 11535244
[TBL] [Abstract][Full Text] [Related]
3. Genetic variability in susceptibility and response to toxicants.
Ingelman-Sundberg M
Toxicol Lett; 2001 Mar; 120(1-3):259-68. PubMed ID: 11323184
[TBL] [Abstract][Full Text] [Related]
4. Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment.
Ingelman-Sundberg M; Oscarson M; McLellan RA
Trends Pharmacol Sci; 1999 Aug; 20(8):342-9. PubMed ID: 10431214
[TBL] [Abstract][Full Text] [Related]
5. The human cytochrome P450 Allele Nomenclature Committee Web site: submission criteria, procedures, and objectives.
Sim SC; Ingelman-Sundberg M
Methods Mol Biol; 2006; 320():183-91. PubMed ID: 16719391
[TBL] [Abstract][Full Text] [Related]
6. Implications of polymorphic cytochrome p450-dependent drug metabolism for drug development.
Ingelman-Sundberg M
Drug Metab Dispos; 2001 Apr; 29(4 Pt 2):570-3. PubMed ID: 11259354
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics: an opportunity for a safer and more efficient pharmacotherapy.
Ingelman-Sundberg M
J Intern Med; 2001 Sep; 250(3):186-200. PubMed ID: 11555122
[TBL] [Abstract][Full Text] [Related]
8. Update on allele nomenclature for human cytochromes P450 and the Human Cytochrome P450 Allele (CYP-allele) Nomenclature Database.
Sim SC; Ingelman-Sundberg M
Methods Mol Biol; 2013; 987():251-9. PubMed ID: 23475683
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
10. The Human Cytochrome P450 Allele Nomenclature Committee Web Site : Submission Criteria, Procedures, and Objectives.
Sim SC; Ingelman-Sundberg M
Methods Mol Biol; 2006; 320():183-191. PubMed ID: 27699669
[TBL] [Abstract][Full Text] [Related]
11. The Human Cytochrome P450 (CYP) Allele Nomenclature website: a peer-reviewed database of CYP variants and their associated effects.
Sim SC; Ingelman-Sundberg M
Hum Genomics; 2010 Apr; 4(4):278-81. PubMed ID: 20511141
[TBL] [Abstract][Full Text] [Related]
12. Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: role in intrauterine toxicity.
Hakkola J; Pelkonen O; Pasanen M; Raunio H
Crit Rev Toxicol; 1998 Jan; 28(1):35-72. PubMed ID: 9493761
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. III. Influence of CYP genetic polymorphism on population differentiation of drug metabolism phenotype.
Tomaszewski P; Kubiak-Tomaszewska G; Łukaszkiewicz J; Pachecka J
Acta Pol Pharm; 2008; 65(3):319-29. PubMed ID: 18646551
[TBL] [Abstract][Full Text] [Related]
14. Update: genetic polymorphism of drug metabolizing enzymes in humans.
Tanaka E
J Clin Pharm Ther; 1999 Oct; 24(5):323-9. PubMed ID: 10583694
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450: genetic polymorphism and drug interactions.
Belpaire FM; Bogaert MG
Acta Clin Belg; 1996; 51(4):254-60. PubMed ID: 8858891
[TBL] [Abstract][Full Text] [Related]
16. Functional consequences of polymorphism of xenobiotic metabolising enzymes.
Ingelman-Sundberg M
Toxicol Lett; 1998 Dec; 102-103():155-60. PubMed ID: 10022248
[TBL] [Abstract][Full Text] [Related]
17. Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics.
Forrester LM; Henderson CJ; Glancey MJ; Back DJ; Park BK; Ball SE; Kitteringham NR; McLaren AW; Miles JS; Skett P
Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):359-68. PubMed ID: 1736885
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapy.
Ingelman-Sundberg M; Rodriguez-Antona C
Philos Trans R Soc Lond B Biol Sci; 2005 Aug; 360(1460):1563-70. PubMed ID: 16096104
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetics of the cytochromes P450.
Daly AK
Curr Top Med Chem; 2004; 4(16):1733-44. PubMed ID: 15579105
[TBL] [Abstract][Full Text] [Related]
20. Recent developments in hepatic drug oxidation. Implications for clinical pharmacokinetics.
Brosen K
Clin Pharmacokinet; 1990 Mar; 18(3):220-39. PubMed ID: 2182263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
